3 data warehouse jobs found in Basel

Mission The mission of Speechify is to make sure that reading is never a barrier to learning. Over 50 million people use Speechify's text-to-speech products to turn whatever they're reading – PDFs, books, Google Docs, news articles, websites – into audio, so they can read faster, read more, and remember more. Speechify's text-to-speech reading products include its iOS app, Android App, Mac App, Chrome Extension, and Web App. Google recently named Speechify the Chrome Extension of the Year and Apple named Speechify its 2025 Design Award winner for Inclusivity. Today, nearly 200 people around the globe work on Speechify in a 100% distributed setting – Speechify has no office. These include frontend and backend engineers, AI research scientists, and others from Amazon, Microsoft, and Google, leading PhD programs like Stanford, high growth startups like Stripe, Vercel, Bolt, and many founders of their own companies What You'll Do Lead the design, architecture,...

Basel Bern St. Gallen Zurich adesso stands for IT excellence and, therefore, for excellent development opportunities for all adessi. We grow together and learn from each other – on our projects, within the team, and through outstanding training programs. We have IT at our core, the industry in our sights, and our customers' success in mind. Because successful business arises from innovative ideas, future-proof strategies, and smart IT solutions. People who want to make a difference and simply do it are always involved. We design and build software that inspires our customers. In challenging projects. And all this in an environment that we enjoy, where success is achieved together, and where everyone feels comfortable. YOU CAN MOVE THIS Concept and development:   You are responsible for the conception, development and design of Java applications in an agile project environment and work on technically demanding software projects....

About us GRANITE BIO is a private biotechnology company located in Basel (Switzerland). GRANITE BIO is supported by top-tier investors with ~$100M raised to date. Based on fundamental research conducted over the last two decades, GRANITE BIO’s is pursuing a differentiated approach to transform inflammatory, autoimmune, and fibrotic conditions. Both our programs are first-in-class monoclonal antibodies for large market opportunities in Immunology and Inflammation. GRT-001, the lead asset, depletes inflammatory monocytes. It has just completed a Phase 1a trial in healthy volunteers and has shown favorable safety and pharmacodynamic effect. The Phase 1b trial in patients with Ulcerative Colitis has just started. GRT-002 is an IL-3 neutralizing antibody that is thought to play an important role in type II inflammation. We are seeking a Data Scientist with strong expertise in data transfers (DTS), statistical analysis, and translational data integration to join our Translational...